source
- Amgen launches late-stage obesity trial in patients who switch from rival drugsAmgen is launching three new late-stage trials for its long-acting obesity shot MariTide, including one designed to test the drug in patients switching away from Eli Lilly and Novo Nordisk's blockb…Endpoints · 3mo ago↗ source
- Q&A: Seaport CEO and CSO on learning from Karuna and the future of CNS researchSeaport Therapeutics began trading as a public company on Friday after executives rang the Nasdaq’s opening bell. Shares rose {$SPTX} more than 20%. With a team largely made up of Karuna Therapeuti…Endpoints · 3mo ago↗ source
- STAT+: Up and down the ladder: The latest comings and goingsHired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and…